Ameriprise Financial Inc Amyris, Inc. Transaction History

Ameriprise Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.09 - $1.82 $2,014 - $3,363	-1,848 Reduced 8.44%	20,043 $27,000
Q4 2022 Feb 14, 2023	SELL	$1.52 - $3.39 $177,689 - $396,294	-116,901 Reduced 84.23%	21,891 $33,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $4.05 $157,035 - $374,114	92,374 Added 199.0%	138,792 $405,000
Q2 2022 Aug 15, 2022	SELL	$1.6 - $5.07 $34,758 - $110,140	-21,724 Reduced 31.88%	46,418 $86,000
Q1 2022 May 16, 2022	BUY	$3.92 - $5.86 $124,373 - $185,926	31,728 Added 87.13%	68,142 $297,000
Q4 2021 Feb 14, 2022	SELL	$5.0 - $14.85 $13,150 - $39,055	-2,630 Reduced 6.74%	36,414 $197,000
Q3 2021 Nov 15, 2021	BUY	$12.13 - $16.99 $473,603 - $663,357	39,044 New	39,044 $536,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.